We use cookies for a better user experience. Read our Privacy Policy

I Agree

Ocular Drug Delivery Technology Market

Ocular Drug Delivery Technology Market (Technology - Topical, Ocular Inserts (Non-Erodible and Erodible), Iontophoresis, Intraocular Implants (Biodegradable and Non-Biodegradable), and In Situ Gel & Punctal Plugs; Formulation Type - Suspension, Solution, Emulsion, Liposomes & Nanoparticles, and Ointments; Disease Type - Glaucoma, Diabetic Retinopathy, Macular Degeneration, Diabetic Macular Edema, and Cataract; End User - Hospitals, Ambulatory Surgical Centers, Ophthalmic Clinics, and Homecare Settings) - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast 2017 - 2025

Global Ocular Drug Delivery Technology Market: Snapshot

Ocular drug delivery is related to the ophthalmic diseases which affect the eye or parts of eyes. According to the report by the World Health Organization (WHO), 1.3 bn people are suffering from vision impairment globally. Rising number of patients suffering from ophthalmic disorders and vision problems are boosting adoption of the ocular drug delivery and likely to fuel the growth of the global ocular drug delivery market.

Additionally, growing aging population globally are more susceptible to suffer from vision impairment is creating the need for effective treatments and drugs are boosting adoption of ocular drug delivery and likely to bolster growth of the global ocular drug delivery market.

Increasing investment in the research and development (R&D) activities in order to develop novel drugs are driving growth of the global ocular drug delivery technology market. Rising approvals from the US Food and Drugs Administration (FDA) are fuelling growth of the global market. Moreover, high number of pipeline drugs and other treatments are expected to offer lucrative opportunities in the global market for key players. Additionally, collaborative steps between vendors and hospitals are creating lucrative opportunities in the global ocular drug delivery technology market.

According to the report by TMR, the global ocular drug delivery technology market is expected to expand with a CAGR of 6.8% over the forecast period from 2017 to 2025 to attain value of US$18.12 bn by the end of forecast period from US$10.2 bn in 2016.

global ocular drug delivery technology market

Rising Number of Patients with Ophthalmic Disorders of to be Beneficial for Growth

On the basis of technology, the global ocular drug delivery technology market is segmented into topical, ocular inserts, intraocular implants, iontophoresis, and in situ gel & punctal plugs. The ocular inserts segment is further classified in to non-erodible and erodible. Intraocular implants segment is further classified into biodegradable and non-biodegradable. Of these,      topical segment dominated the global market in 2016, with more than 50% of the overall shares in the global market for ocular drug delivery technology. Thanks to these factors, the segment is expected to expand with 6.6% from 2017 to 2025.

On the basis of formulation type, the global infusion pumps market is segmented into suspension, solution, liposomes & nanoparticles, emulsion, and ointments. Based on the disease type, the global infusion pumps market is segmented into glaucoma, macular degeneration, diabetic retinopathy, diabetic macular edema, and cataract.

Growing Investments for Improvement of Healthcare Sector to Bolster Growth

On the basis of region, the global ocular drug delivery technology market is segmented into North America, Asia Pacific, Europe, Latin America, and Middle East & Africa. Of these, North America is dominating the global market for ocular drug delivery technology and expected to continue its dominance over the forecast period tailed by Europe. Growth in the North America region is attributable to the demand for the targeted drug delivery systems. In 2016, the region accounted for massive 52.5% shares in the overall market. The European market accounted for 24% of the shares in the same year. However, Asia Pacific is expected to expand with higher CAGR over the forecast period thanks to the growing initiatives from the government for improving healthcare facilities.

Some of the prominent players operating in the ocular drug delivery technology market include OCULAR THERAPEUTIX, INC., Allergan, Plc., Alimera Sciences, EyeGate Pharma, and Valeant Pharmaceuticals International, Inc. the market has highly consolidated vendor landscape. The top three companies such as Santen Pharmaceutical Co., Ltd., Alimera Sciences, and Valeant Pharmaceuticals International, Inc. accounted for 50% of the shares in the overall market.

High Prevalence of Ophthalmic Disorders fuels Global Ocular Drug Delivery Technology Market

Ophthalmic diseases, which involve the eye or portions of the eye, are linked to ocular drug delivery.  As per the WHO (World Health Organization), around 1.3 billion people worldwide suffer from visual disability. The growing number of people suffering from vision-related issues and ophthalmic disorders is likely to better the acceptance of ocular drug delivery. This factor is expected to trigger development of the global ocular drug delivery technology market in the years to come.

In addition to that, the world's ageing population is increasing the need for successful medicines and medications, which is driving up the acceptance of ocular drug delivery. This factor is likely to support development of the global ocular drug delivery technology market.

Growth of the Market to Ride on the Back of Favorable Reimbursement Policies

The global ocular drug delivery technology market is predicted to rise due to many reasons, such as increased occurrence of ophthalmic disorders, rise in incidences of macular degeneration and  glaucoma incidence and . Furthermore, the industry is projected to be influenced by a rise in the number of approvals from federal regulations, favourable reimbursement policies, and increased investment to create innovative drug delivery systems. The need for ocular drug delivery technologies is expected to be fueled by the low bioavailability of drugs used in traditional ocular therapies.

Nonetheless, annoyance and pain in some patients, as well as dilution attributable to the stiffness of the implants, are likely to restrain global ocular drug delivery technology market in the years to come. Augmented demand for targeted drug delivery, particularly for posterior eye disorders, as well as increasing penetration of low molecular size particles, is likely to boost the scope of formulations of liposome and nanoparticle. Nanoparticles are also said to have longer ocular surface resistance time.

North America is set to maintain its dominance in the global ocular drug delivery technology market. The market in North America is expected to grow due to an emergence of a significant number of market players, high cost of ocular surgery and an increase in the number of instances of vision impairments.

The Global Ocular Drug Delivery Technology Market has been segmented as given below: 

by Technology

  • Topical
  • Ocular Insert
  • Erodible
  • Non-Erodible
  • Iontophoresis
  • Intraocular Implants
  • Biodegradable
  • Non-Biodegradable
  • In Situ Gel & Punctal Plugs
  • Others 

by Formulation Type

  • Solution
  • Suspension
  • Emulsion
  • Liposomes & Nanoparticles
  • Ointment

by Disease Type

  • Glaucoma
  • Macular Degeneration
  • Diabetic Retinopathy
  • Cataract
  • Diabetic Macular Edema
  • Dry Eye Syndrome
  • Others

by End user

  • Hospitals
  • Ambulatory Surgical centers
  • Ophthalmic Clinics
  • Homecare Settings

by Region

  • North America
    • U.S.
    • Canada
  • Europe
    • Germany
    • U.K.
    • France
    • Italy
    • Spain
    • Russia
    • Rest of Europe
  • Asia Pacific
    • India
    • China
    • Japan
    • Australia & New Zealand
    • Rest of Asia Pacific
  • Latin America
    • Brazil
    • Mexico
    • Rest of Latin America
  • Middle East & Africa
    • GCC Countries
    • South Africa
    • Rest of Middle East & Africa
Ocular Drug Delivery Technology Market

Interested in this report?
Get a FREE Brochure now!

Get Free Brochure

*Get Brochure Report (PDF) sent to your email within minutes

1. Preface
     1.1. Market Definition and Scope
     1.2. Market Segmentation
     1.3. Key Research Objectives
     1.4. Research Highlights

2. Assumptions and Research Methodology

3. Executive Summary : Global Ocular Drug Delivery Disease Type Market

4. Market Overview
     4.1. Introduction
             4.1.1. Disease Type Definition
             4.1.2. Industry Evolution / Developments
     4.2. Overview
     4.3. Key Market Indicators
             4.3.1. Region/Country Specific
             4.3.2. Product/Application/Disease Type Specific
             4.3.3. Target Market Specific – Global Scenario
     4.4. Market Dynamics
             4.4.1. Drivers
             4.4.2. Restraints
             4.4.3. Opportunity
     4.5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, 2015–2025
     4.6. Ocular Drug Delivery Disease Type Market - Global Supply Demand Scenario
     4.7. Porter’s Five Force Analysis
     4.8. Market Outlook
     4.9. Ocular Drug Delivery Technology: Pipeline Analysis

5. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
     5.1. Introduction & Definition
     5.2. Key Findings / Developments
     5.3. Key Trends
     5.4. Market Value Forecast By Disease Type , 2015–2025
             5.4.1. Topical
             5.4.2. Ocular Insert
                        5.4.2.1. Erodible
                        5.4.2.2. Non-Erodible
             5.4.3. Iontophoresis
             5.4.4. Intraocular Implant
                        5.4.4.1. Biodegradable 
                        5.4.4.2. Non-Biodegradable
             5.4.5. In Situ Gel & Punctal Plug
             5.4.6. Others
     5.5. Market Attractiveness By Disease Type 

6. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Formulation Type 
     6.1. Introduction & Definition
     6.2. Key Findings / Developments
     6.3. Key Trends
     6.4. Market Value Forecast By Formulation Type , 2015–2025
             6.4.1. Solution
             6.4.2. Suspension
             6.4.3. Emulsion
             6.4.4. Liposomes & Nanoparticles
             6.4.5. Ointments
     6.5. Market Attractiveness By Formulation Type 

7. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Disease Type 
     7.1. Introduction & Definition
     7.2. Key Findings / Developments
     7.3. Key Trends
     7.4. Market Value Forecast By Disease Type , 2015–2025
             7.4.1. Diabetic Retinopathy
             7.4.2. Macular Degeneration
             7.4.3. Cataract
             7.4.4. Glaucoma
             7.4.5. Diabetic Macular Edema
             7.4.6. Dry Eye Syndrome
             7.4.7. Others
     7.5. Market Attractiveness By Disease Type 

8. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By End User 
     8.1. Introduction & Definition
     8.2. Key Findings / Developments
     8.3. Key Trends
     8.4. Market Value Forecast By End User , 2015–2025
             8.4.1. Hospitals
             8.4.2. Ambulatory Surgical Centers
             8.4.3. Ophthalmic Clinics
             8.4.4. Homecare Settings
     8.5. Market Attractiveness By End User 

9. Global Ocular Drug Delivery Disease Type Market Analysis and Forecasts, By Region
     9.1. Key Findings
     9.2. Policies and Regulations
     9.3. Market Value Forecast By Region
             9.3.1. North America 
             9.3.2. Europe 
             9.3.3. Asia Pacific 
             9.3.4. Latin America 
             9.3.5. Middle East & Africa 
     9.4. Market Attractiveness By Country/Region

10. North America Ocular Drug Delivery Disease Type Market Analysis and Forecast
     10.1. Introduction
             10.1.1. Key Findings
             10.1.2. Policies and Regulations
             10.1.3. Price Trend Analysis
             10.1.4. Key Trends
     10.2. Market Value Forecast By Disease Type , 2015–2025
             10.2.1. Topical
             10.2.2. Ocular Insert
                        10.2.2.1. Erodible
                        10.2.2.2. Non-Erodible
             10.2.3. Iontophoresis
             10.2.4. Intraocular Implant
                        10.2.4.1. Biodegradable 
                        10.2.4.2. Non-Biodegradable
             10.2.5. In Situ Gel & Punctal Plug
             10.2.6. Others
     10.3. Market Value Forecast By Formulation Type , 2015–2025
             10.3.1. Solution
             10.3.2. Suspension
             10.3.3. Emulsion
             10.3.4. Liposomes & Nanoparticles
             10.3.5. Ointments
     10.4. Market Value Forecast By Disease Type , 2015–2025
             10.4.1. Diabetic Retinopathy
             10.4.2. Macular Degeneration
             10.4.3. Cataract
             10.4.4. Glaucoma
             10.4.5. Diabetic Macular Edema
             10.4.6. Dry Eye Syndrome
             10.4.7. Others
     10.5. Market Value Forecast By End User , 2015–2025
             10.5.1. Hospitals
             10.5.2. Ambulatory Surgical Centers
             10.5.3. Ophthalmic Clinics
             10.5.4. Homecare Settings
     10.6. Market Value Forecast By Country , 2015–2025
             10.6.1. U.S.
             10.6.2. Canada
     10.7. Market Attractiveness Analysis 
             10.7.1. By Disease Type 
             10.7.2. By Formulation Type 
             10.7.3. By Disease Type 
             10.7.4. By End User 
             10.7.5. By Country

11. Europe Ocular Drug Delivery Disease Type Market Analysis and Forecast
     11.1. Introduction
             11.1.1. Key Findings
             11.1.2. Policies and Regulations
             11.1.3. Price Trend Analysis
             11.1.4. Key Trends
     11.2. Market Value Forecast By Disease Type , 2015–2025
             11.2.1. Topical
             11.2.2. Ocular Insert
                        11.2.2.1. Erodible
                        11.2.2.2. Non-Erodible
             11.2.3. Iontophoresis
             11.2.4. Intraocular Implant
                        11.2.4.1. Biodegradable 
                        11.2.4.2. Non-Biodegradable
             11.2.5. In Situ Gel & Punctal Plug
             11.2.6. Others
     11.3. Market Value Forecast By Formulation Type , 2015–2025
             11.3.1. Solution
             11.3.2. Suspension
             11.3.3. Emulsion
             11.3.4. Liposomes & Nanoparticles
             11.3.5. Ointments
     11.4. Market Value Forecast By Disease Type , 2015–2025
             11.4.1. Diabetic Retinopathy
             11.4.2. Macular Degeneration
             11.4.3. Cataract
             11.4.4. Glaucoma
             11.4.5. Diabetic Macular Edema
             11.4.6. Dry Eye Syndrome
             11.4.7. Others
     11.5. Market Value Forecast By End User , 2015–2025
             11.5.1. Hospitals
             11.5.2. Ambulatory Surgical Centers
             11.5.3. Ophthalmic Clinics
             11.5.4. Homecare Settings
     11.6. Market Value Forecast By Country , 2015–2025
             11.6.1. U.K.
             11.6.2. Germany
             11.6.3. France
             11.6.4. Italy
             11.6.5. Russia
             11.6.6. Spain
             11.6.7. Rest of Europe
     11.7. Market Attractiveness Analysis 
             11.7.1. By Disease Type 
             11.7.2. By Formulation Type 
             11.7.3. By Disease Type 
             11.7.4. By End User 
             11.7.5. By Country

12. Asia Pacific Ocular Drug Delivery Disease Type Market Analysis and Forecast
     12.1. Introduction
             12.1.1. Key Findings
             12.1.2. Policies and Regulations
             12.1.3. Price Trend Analysis
             12.1.4. Key Trends
     12.2. Market Value Forecast By Disease Type , 2015–2025
             12.2.1. Topical
             12.2.2. Ocular Insert
                        12.2.2.1. Erodible
                        12.2.2.2. Non-Erodible
             12.2.3. Iontophoresis
             12.2.4. Intraocular Implant
                        12.2.4.1. Biodegradable 
                        12.2.4.2. Non-Biodegradable
             12.2.5. In Situ Gel & Punctal Plug
             12.2.6. Others
     12.3. Market Value Forecast By Formulation Type , 2015–2025
             12.3.1. Solution
             12.3.2. Suspension
             12.3.3. Emulsion
             12.3.4. Liposomes & Nanoparticles
             12.3.5. Ointments
     12.4. Market Value Forecast By Disease Type , 2015–2025
             12.4.1. Diabetic Retinopathy
             12.4.2. Macular Degeneration
             12.4.3. Cataract
             12.4.4. Glaucoma
             12.4.5. Diabetic Macular Edema
             12.4.6. Dry Eye Syndrome
             12.4.7. Others
     12.5. Market Value Forecast By End User , 2015–2025
             12.5.1. Hospitals
             12.5.2. Ambulatory Surgical Centers
             12.5.3. Ophthalmic Clinics
             12.5.4. Homecare Settings
     12.6. Market Value Forecast By Country , 2015–2025
             12.6.1. China
             12.6.2. Japan
             12.6.3. India
             12.6.4. Australia & New Zealand
             12.6.5. Rest of Asia Pacific
     12.7. Market Attractiveness Analysis 
             12.7.1. By Disease Type 
             12.7.2. By Formulation Type 
             12.7.3. By Disease Type 
             12.7.4. By End User 
             12.7.5. By Country

13. Latin America Ocular Drug Delivery Disease Type Market Analysis and Forecast
     13.1. Introduction
             13.1.1. Key Findings
             13.1.2. Policies and Regulations
             13.1.3. Price Trend Analysis
             13.1.4. Key Trends
     13.2. Market Value Forecast By Disease Type , 2015–2025
             13.2.1. Topical
             13.2.2. Ocular Insert
                        13.2.2.1. Erodible
                        13.2.2.2. Non-Erodible
             13.2.3. Iontophoresis
             13.2.4. Intraocular Implant
                        13.2.4.1. Biodegradable 
                        13.2.4.2. Non-Biodegradable
             13.2.5. In Situ Gel & Punctal Plug
             13.2.6. Others
     13.3. Market Value Forecast By Formulation Type , 2015–2025
             13.3.1. Solution
             13.3.2. Suspension
             13.3.3. Emulsion
             13.3.4. Liposomes & Nanoparticles
             13.3.5. Ointments
     13.4. Market Value Forecast By Disease Type , 2015–2025
             13.4.1. Diabetic Retinopathy
             13.4.2. Macular Degeneration
             13.4.3. Cataract
             13.4.4. Glaucoma
             13.4.5. Diabetic Macular Edema
             13.4.6. Dry Eye Syndrome
             13.4.7. Others
     13.5. Market Value Forecast By End User , 2015–2025
             13.5.1. Hospitals
             13.5.2. Ambulatory Surgical Centers
             13.5.3. Ophthalmic Clinics
             13.5.4. Homecare Settings
     13.6. Market Value Forecast By Country , 2015–2025
             13.6.1. Brazil
             13.6.2. Mexico
             13.6.3. Rest of Latin America
     13.7. Market Attractiveness Analysis 
             13.7.1. By Disease Type 
             13.7.2. By Formulation Type 
             13.7.3. By Disease Type 
             13.7.4. By End User 
             13.7.5. By Country

14. Middle East & Africa Ocular Drug Delivery Disease Type Market Analysis and Forecast
     14.1. Introduction
             14.1.1. Key Findings
             14.1.2. Policies and Regulations
             14.1.3. Price Trend Analysis
             14.1.4. Key Trends
     14.2. Market Value Forecast By Disease Type , 2015–2025
             14.2.1. Topical
             14.2.2. Ocular Insert
                        14.2.2.1. Erodible
                        14.2.2.2. Non-Erodible
             14.2.3. Iontophoresis
             14.2.4. Intraocular Implant
                        14.2.4.1. Biodegradable 
                        14.2.4.2. Non-Biodegradable
             14.2.5. In Situ Gel & Punctal Plug
             14.2.6. Others
     14.3. Market Value Forecast By Formulation Type , 2015–2025
             14.3.1. Solution
             14.3.2. Suspension
             14.3.3. Emulsion
             14.3.4. Liposomes & Nanoparticles
             14.3.5. Ointments
     14.4. Market Value Forecast By Disease Type , 2015–2025
             14.4.1. Diabetic Retinopathy
             14.4.2. Macular Degeneration
             14.4.3. Cataract
             14.4.4. Glaucoma
             14.4.5. Diabetic Macular Edema
             14.4.6. Dry Eye Syndrome
             14.4.7. Others
     14.5. Market Value Forecast By End User , 2015–2025
             14.5.1. Hospitals
             14.5.2. Ambulatory Surgical Centers
             14.5.3. Ophthalmic Clinics
             14.5.4. Homecare Settings
     14.6. Market Value Forecast By Country , 2015–2025
             14.6.1. GCC Countries
             14.6.2. South Africa
             14.6.3. Rest of Middle East and Africa
     14.7. Market Attractiveness Analysis 
             14.7.1. By Disease Type 
             14.7.2. By Formulation Type 
             14.7.3. By Disease Type 
             14.7.4. By End User 
             14.7.5. By Country

15. Competition Landscape
     15.1. Market Player – Competition Matrix (By Tier and Size of companies)
     15.2. Market Share Analysis By Company (2015)
     15.3. Company Profiles 
             15.3.1. OCULAR THERAPEUTIX, INC. 
                        15.3.1.1. Overview
                        15.3.1.2. Financials
                        15.3.1.3. Recent Developments
                        15.3.1.4. Strategy
             15.3.2. Alimera Sciences
                        15.3.2.1. Overview
                        15.3.2.2. Financials
                        15.3.2.3. Recent Developments
                        15.3.2.4. Strategy
             15.3.3. Allergan, Plc 
                        15.3.3.1. Overview
                        15.3.3.2. Financials
                        15.3.3.3. Recent Developments
                        15.3.3.4. Strategy
             15.3.4. Valeant Pharmaceuticals International, Inc. (Bausch & Lomb Incorporated)
                        15.3.4.1. Overview
                        15.3.4.2. Financials
                        15.3.4.3. Recent Developments
                        15.3.4.4. Strategy
             15.3.5. EyeGate Pharma 
                        15.3.5.1. Overview
                        15.3.5.2. Financials
                        15.3.5.3. Recent Developments
                        15.3.5.4. Strategy
             15.3.6. Envisia Therapeutics 
                        15.3.6.1. Overview
                        15.3.6.2. Financials
                        15.3.6.3. Recent Developments
                        15.3.6.4. Strategy
             15.3.7. Clearside Biomedical, INC. 
                        15.3.7.1. Overview
                        15.3.7.2. Financials
                        15.3.7.3. Recent Developments
                        15.3.7.4. Strategy
             15.3.8. Graybug Vision Inc. 
                        15.3.8.1. Overview
                        15.3.8.2. Financials
                        15.3.8.3. Recent Developments
                        15.3.8.4. Strategy
             15.3.9. Santen Pharmaceutical Co., Ltd 
                        15.3.9.1. Overview
                        15.3.9.2. Financials
                        15.3.9.3. Recent Developments
                        15.3.9.4. Strategy
             15.3.10. Taiwan Liposome Company, Ltd
                        15.3.10.1. Overview
                        15.3.10.2. Financials
                        15.3.10.3. Recent Developments
                        15.3.10.4. Strategy 

List of Tables

Table 01: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 02: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 03: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, Intraocular Implants, 2015–2025
Table 04: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 05: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 06: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 07: Global Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Region, 2015–2025
Table 08: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 09: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 10: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 11: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 12: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 13: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 14: North America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025
Table 15: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 16: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 17: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 18: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 19: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 20: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 21: Europe Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 22: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 23: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 24: Asia Pacific Ocular Drug Delivery Technology Market, by Ocular Inserts, Market Size (US$ Mn) Forecast, 2015–2025
Table 25: Asia Pacific Ocular Drug Delivery Technology Market, by Intraocular Implants, Market Size (US$ Mn) Forecast, 2015–2025
Table 26: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 27: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 28: Asia Pacific Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End User, 2015–2025
Table 29: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 30: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 31: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 32: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 33: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 34: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 35: Latin America Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End Users, 2015–2025
Table 36: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Country, 2015–2025
Table 37: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Technology Type, 2015–2025
Table 38: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Ocular Inserts, 2015–2025
Table 39: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Intraocular Implants, 2015–2025
Table 40: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Formulation Type, 2015–2025
Table 41: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by Disease Type, 2015–2025
Table 42: Middle East & Africa Ocular Drug Delivery Technology Market Size (US$ Mn) Forecast, by End-user, 2015–2025

List of Figures

Figure 1: Global Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast, 2015–2025
Figure 2: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type (2016)
Figure 3: Global Ocular Drug Delivery Technology Market Value Share, by Formulations Type (2016)
Figure 04: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type (2016)
Figure 05: Global Ocular Drug Delivery Technology Market Value Share, by Region (2016)
Figure 06: Global Ocular Drug Delivery Technology Market Value Share, by End-user (2016)
Figure 07: Global Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 08: Global Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 09: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Topical, 2015–2025
Figure 10: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ocular Inserts, 2015–2025
Figure 11: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Iontophoresis, 2015–2025
Figure 12: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Intraocular Implants, 2015–2025
Figure 13: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by In Situ Gel & Punctal Plugs, 2015–2025
Figure 14: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Other Technology, 2015–2025
Figure 15: Global Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 16: Global Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 17: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Suspension, 2015–2025
Figure 18: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Solution, 2015–2025
Figure 19: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Liposome & Nanoparticle, 2015–2025
Figure 20: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Emulsion, 2015–2025
Figure 21: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth Projection (%), by Ointment, 2015–2025
Figure 22: Global Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 23: Global Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 24: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Glaucoma, 2015–2025
Figure 25: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Retinopathy, 2015–2025
Figure 26: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Dry Eye Syndrome, 2015–2025
Figure 27: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Macular Degeneration, 2015–2025
Figure 28: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Diabetic Macular Edema, 2015–2025
Figure 29: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Cataract, 2015–2025
Figure 30: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Others, 2015–2025
Figure 31: Global Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 32: Global Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 33: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Hospitals, 2015–2025
Figure 34: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by ASCs, 2015–2025
Figure 35: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Ophthalmic Clinics, 2015–2025
Figure 36: Global Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, by Home Care Settings, 2015–2025
Figure 37: Global Ocular Drug Delivery Technology Market Value Share, by Region, 2017 and 2025 
Figure 38: Global Ocular Drug Delivery Technology Market Attractiveness, by Region, 2017–2025
Figure 39: North America Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 40: North America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 41: North America Ocular Drug Delivery Technology Market Attractiveness, 2017–2025
Figure 42: North America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 43: North America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 44: North America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 45: North America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 46: North America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 47: North America Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 48: North America Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 49: North America Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 50: Europe Ocular Drug Delivery Technology Market Revenue (US$ Mn) and Y-o-Y Growth (%) Forecast, 2015–2025
Figure 51: Europe Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 52: Europe Ocular Drug Delivery Technology Market Attractiveness, by Country, 2017–2025
Figure 53: Europe Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 54: Europe Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 55: Europe Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 56: Europe Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 57: Europe Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 58: Europe Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 59: Europe Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 60: Europe Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017-2025
Figure 61: Asia Pacific Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 62: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 63: Asia Pacific Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 64: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 65: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 66: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 67: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 68: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 69: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017-2025
Figure 70: Asia Pacific Ocular Drug Delivery Technology Market Value Share, by End User, 2017 and 2025
Figure 71: Asia Pacific Ocular Drug Delivery Technology Market Attractiveness, by End User, 2017–2025
Figure 72: Latin America Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 73: Latin America Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 74: Latin America Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 75: Latin America Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 76: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017-2025
Figure 77: Latin America Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 78: Latin America Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017–2025
Figure 79: Latin America Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 80: Latin America Ocular Drug Delivery Technology  Market Attractiveness, by Disease Type, 2017-2025
Figure 81: Latin America Ocular Drug Delivery Technology Market Value Share, by End Users, 2017 and 2025
Figure 82: Latin America Ocular Drug Delivery Technology Market Attractiveness, by End Users, 2017–2025
Figure 83: Middle East & Africa Ocular Drug Delivery Technology, Market Size (US$ Mn) Forecast and Y-o-Y Growth (%), 2015–2025
Figure 84: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Country, 2017 and 2025 
Figure 85: Middle East & Africa Ocular Drug Delivery Technology, Market Attractiveness, by Country, 2017–2025
Figure 86: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Technology Type, 2017 and 2025
Figure 87: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Technology Type, 2017–2025
Figure 88: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Formulation Type, 2017 and 2025
Figure 89: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Formulation Type, 2017-2025
Figure 90: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by Disease Type, 2017 and 2025
Figure 91: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by Disease Type, 2017–2025
Figure 92: Middle East & Africa Ocular Drug Delivery Technology Market Value Share, by End-user, 2017 and 2025
Figure 93: Middle East & Africa Ocular Drug Delivery Technology Market Attractiveness, by End-user, 2017–2025
Figure 94: Global Ocular Drug Delivery Technology  Market Share, by Company, 2016

Transparency Market Research Plus
  • We offer 100% free customisation with our Enterprise License!!
  • Get a free copy if the report you purchased is updated within 90 days
  • Regardless from where you have purchased the report, you can request an updated version of the report from us.

Complete the form below and we'll get back to you shortly.

269

Your personal details are safe with us. Privacy Policy*

Copyright © Transparency Market Research, Inc. All Rights reserved